Erratum: A phase 2 randomized, double-blind, placebo-controlled study of the safety and efficacy of talactoferrin in patients with severe sepsis

Alejandro Arroliga, Robert Balk, Chad Cannon, Nathan Dean, Phillip Dellinger, Paula Dennen, Juan Figueroa, Eugene Fletcher, Kalpalatha K. Guntupalli, David T. Huang, Mitchell Levy, Takkin Lo, Imrana Malik, Benjamin Margolis, George Matuschak, Laura Moore, Gregory J. Moran, Eugene Moretti, Peter Morris, Edward PanacekEmanual Rivers, Greg Schmidt, Michael G. Seneff, Jay Steingrub, Robert Taylor

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)e390
JournalCritical Care Medicine
Volume42
Issue number5
DOIs
StatePublished - May 2014

Bibliographical note

Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Fingerprint

Dive into the research topics of 'Erratum: A phase 2 randomized, double-blind, placebo-controlled study of the safety and efficacy of talactoferrin in patients with severe sepsis'. Together they form a unique fingerprint.

Cite this